Keywords: benefit, eloxatin, chemo, plus, avastin, french, drugmaker

Benefit of Eloxatin chemo plus Avastin

Article | 07 February 2005

French drugmaker Sanofi-Aventis has reported encouraging preliminary results from two large prospective trials investigating the safety and efficacy of Eloxatin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Genentech

Roche

Go to company listing

Related Drugs

Avastin

bevacizumab

Eloxatin

Oxaliplatin Injection

Amino Acids

Go to drug listing